Clinical Trial Update: ADMIRAL Trial: Adaptive Mediastinal Radiation With Chemo-Immunotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial update for ADMIRAL evaluating adaptive mediastinal radiation with chemo-immunotherapy in locally advanced non-small cell lung cancer; study termin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer
• Non-small Cell Lung Cancer

Snippet

Sponsor: University of Washington | Conditions: Locally Advanced Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8 | Phase 2 | Status: TERMINATED | Results posted: 2023-06-13